- Researchers tested a new antibody treatment in patients.
- It targets the blood cancer called multiple myeloma.
- The medicine has the name linvoseltamab.
- Doctors gave several treatment cycles to participants.
- Doctors used very sensitive bone marrow tests.
- The tests did not find cancer cells afterward.
- Some patients had low white blood cells.
- Serious immune reactions did not occur.
- Results are early but appear promising.
- The team will continue testing this treatment.
Difficult words
- antibody — A protein the immune system uses to fight germs
- multiple myeloma — A blood cancer that starts in bone marrow
- bone marrow — Soft tissue inside bones that makes blood cells
- white blood cell — A blood cell that helps fight infection and diseasewhite blood cells
- promising — Showing signs of future success or good results
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you try a new medicine in a medical test?
- Have you ever had a blood test?
- How do you feel if a test shows no cancer?
Related articles
Plague and the role of human fleas in Madagascar
The plague is still endemic in some countries, including Madagascar. Researchers found that the human flea Pulex irritans contributes to outbreaks and that household conditions and insecticide use influence flea levels and control efforts.
Clock disruption speeds breast cancer in models
New research finds that repeating disruption of the body’s 24-hour clock changes breast tissue, weakens immune defenses and leads to faster, more aggressive breast cancer in experimental models. The study links altered light–dark schedules to worse outcomes.
Cherry compounds may slow triple-negative breast cancer
Researchers at Texas A&M report that anthocyanins from dark sweet cherries slowed tumour growth and reduced metastasis in mice, and that combining them with chemotherapy helped control tumours. Further research is needed on safety and absorption.